Search for Clinical Trial Results
Kawasaki Disease - 25 Studies Found
Status | Study |
Withdrawn |
Study Name: Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease Condition: Kawasaki Disease Date: 2006-03-20 Interventions: Drug: pravastatin |
Withdrawn |
Study Name: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Condition: Kawasaki Disease Date: 2016-10-24 Interventions: Drug: Canakinumab Other Name: ACZ885 |
Recruiting |
Study Name: Etiology Study of Kawasaki Disease Condition: Kawasaki Disease Date: 2005-09-09 |
Completed |
Study Name: Infliximab (Remicade) for Patients With Acute Kawasaki Disease Condition: Kawasaki Disease Date: 2005-12-30 Interventions:
|
Completed |
Study Name: Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease Condition: Kawasaki Disease Date: 2012-01-25 Interventions: Drug: immunoglobulin G Intravenously administer a single dose of the product (2g/kg) for at least 12 hou |
Completed |
Study Name: A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease Condition: Kawasaki Disease Date: 2005-09-09 Interventions: Drug: Sestamibi Sestamibi Other Name: Cardiolite |
Active, not recruiting |
Study Name: Etanercept in Kawasaki Disease Condition:
|
Recruiting |
Study Name: KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) Condition: Mucocutaneous Lymph Node Syndrome Date: 2017-01-17 Interventions:
|
Completed |
Study Name: Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease Condition: Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin Date: 2012-05-09 Interventions:
|
Recruiting |
Study Name: Anakinra and Kawasaki Disease Condition:
Date: 2015-03-11 Interventions: Drug: Anakinra The dose of Anakinra will be 2mg/kg. If the patient remains febrile (fever >38°C) |